Function Clinical Trials

1,448 recruitingLast updated: July 25, 2026

There are 1,448 actively recruiting function clinical trials across 86 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4, Phase 1, Early Phase 1. Top locations include New York, New York, United States, Houston, Texas, United States, Los Angeles, California, United States. Updated daily from ClinicalTrials.gov.


Function Trials at a Glance

1,448 actively recruiting trials for function are listed on ClinicalTrialsFinder across 6 cities in 86 countries. The largest study group is Not Applicable with 719 trials, with the heaviest enrollment activity in New York, Houston, and Los Angeles. Lead sponsors running function studies include Cairo University, University of Colorado, Denver, and Foundation University Islamabad.

Treatments under study

About Function Clinical Trials

Looking for clinical trials for Function? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Function trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Function clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 1,448 trials

Recruiting
Not Applicable

Long-Term Effects of Walnut Consumption on Brain Function

HealthyCognitive DeclineAbdominal Obesity+6 more
Maastricht University Medical Center55 enrolled1 locationNCT07422220
Recruiting
Phase 4

Postpartum Vaginal Estrogen for Breastfeeding Patients

BreastfeedingVaginal AtrophyPostpartum Sexual Dysfunction
University Hospitals Cleveland Medical Center100 enrolled1 locationNCT05457972
Recruiting
Not Applicable

Effect of Daily Mixed Spice Consumption on Memory Function

Cognitive FunctionMemory
University of California, Los Angeles50 enrolled1 locationNCT06889961
Recruiting
Phase 4

SGLT2i Therapy in Islet Transplantation (SIT)

DiabetesPartial Islet FunctionTPIAT
University of Minnesota40 enrolled1 locationNCT07228195
Recruiting
Not Applicable

COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

Complex Congenital Heart DefectDysfunctional RVOT ConduitPulmonary Valve Insufficiency+1 more
Edwards Lifesciences108 enrolled27 locationsNCT02744677
Recruiting

Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

Primary Graft DysfunctionLung transplantation
University of Pennsylvania1,150 enrolled1 locationNCT00552357
Recruiting
Not Applicable

Effects of Stecco Fascial Manipulation Versus Muscle Energy Technique on Pain Pressure Threshold, Range of Motion and Disability Among Patients With Sacroiliac Joint Dysfunction

Sacroiliac Joint Dysfunction
Lahore University of Biological and Applied Sciences52 enrolled1 locationNCT07723014
Recruiting

A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD

Metabolic Dysfunction-Associated Steatotic Liver DiseasePlaque Psoriasis
Novartis Pharmaceuticals150 enrolled3 locationsNCT07683065
Recruiting

Cognitive Dysfunction and Delirium After TUR-M in Elderly Patients

Cognitive DysfunctionPostoperative DeliriumPostoperative Cognitive Dysfunction
Muğla Sıtkı Koçman University150 enrolled1 locationNCT07719712
Recruiting

The Relationship Between Transversus Abdominis Muscle Architecture and Upper Extremity Function in Patients With Chronic Low Back Pain

UltrasoundLow Back PainScapular Dyskinesis+2 more
Ilayda Dilan Isik90 enrolled1 locationNCT07474610
Recruiting
Not Applicable

Comparison of Core Stability and Hip Strengthening Protocols in Sacroiliac Joint Dysfunction

Sacroiliac Joint Dysfunction
Riphah International University22 enrolled1 locationNCT07716215
Recruiting
Phase 2

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Cognitive DysfunctionLewy Body DiseaseAmyloid+1 more
Eli Lilly and Company350 enrolled72 locationsNCT07589595
Recruiting
Phase 3

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company4,500 enrolled563 locationsNCT07165028
Recruiting
Phase 2

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Metabolic Dysfunction-Associated Steatohepatitis
Eccogene160 enrolled62 locationsNCT07288138
Recruiting

Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques

TicsFunctional Tics
National Institute of Neurological Disorders and Stroke (NINDS)75 enrolled1 locationNCT07137442
Recruiting

Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up

Sinus Node DysfunctionAtrioventricular BlockBundle-Branch Block+1 more
Boston Scientific Corporation140 enrolled13 locationsNCT07209852
Recruiting
Early Phase 1

Antidepressant Therapy for Improved Blood Vessel Health After Preeclampsia

PreeclampsiaEndothelial function
Anna Stanhewicz, PhD40 enrolled1 locationNCT07715669
Recruiting
Phase 2

Role of Estrogen on Skeletal Outcomes in FHA

Bone DensityFHA (Functional Hypothalamic Amenorrhea)Bone Strength
University of Virginia150 enrolled2 locationsNCT07010146
Recruiting
Not Applicable

Independent and Combined Effects of Short-term Sulforaphane Supplementation and Exercise on Immunometabolism in Healthy Adults

InflammationImmunometabolismMitochondrial Function, Bioenergetics
University of British Columbia20 enrolled1 locationNCT07668596
Recruiting

Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation

Atrial FibrillationFunctional Mitral RegurgitationFunctional Tricuspid Regurgitation
Barts & The London NHS Trust60 enrolled1 locationNCT05920824